key: cord-0769137-z69aa33j
authors: Chinnadurai, Rajkumar; Ramgobin, Chittesh; Wu, Henry H. L.; Hayes, Emma; Collier, Joanne; Lewis, David; Poulikakos, Dimitrios
title: Long‐term antibody response following COVID‐19 vaccination in patients receiving peritoneal dialysis
date: 2022-03-29
journal: Semin Dial
DOI: 10.1111/sdi.13079
sha: c9a92ce9e9f8b0687498ee122127a606fcae5d63
doc_id: 769137
cord_uid: z69aa33j

nan

differential early immune response to BNT162b2 and AZD1222 vaccines with the latter inducing suboptimal neutralizing antibody levels. 5 The duration of detectable humoral response following AZ1222 and BNT162b2 vaccines with UK extended dosing interval (6-14 weeks) in PD patients is unknown. We present data on long-term antibody response following two doses of AZ1222 or BNT162b2 vaccines with UK dosing intervals for 72 PD patients in our center.

COVID-19 antibody testing was performed using Siemens' immunoassay targeting the spike protein S1 RBD (index ≥1.0 was 

Similar humoral immune responses in peritoneal dialysis and haemodialysis patients after two doses of the SARS-CoV-2 vaccine BNT162b2

Immunogenicity and tolerability of COVID-19 vaccination in peritoneal dialysis patients-a prospective observational cohort study

Antibody responses to inactivated SARS-CoV-2 vaccine in peritoneal dialysis patients

Comparison of long-term antibody response to mRNA SARS-CoV-2 vaccine among peritoneal dialysis and hemodialysis patients

Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients

https://orcid.org/0000-0003-3973-6595Henry H. L. Wu https://orcid.org/0000-0002-4561-0844